Market Overview:
The global Tegafur API market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for Tegafur API in various applications such as injection and other applications. North America is expected to dominate the global Tegafur API market during the forecast period, followed by Europe and Asia Pacific. Latin America and Middle East & Africa are expected to grow at a high CAGR during the forecast period.
Product Definition:
Tegafur API is used to identify the presence of Tegafur in a sample. It is important because it can be used as an indicator of whether or not a patient has been taking this medication.
Purity ≥ 98 %:
Tegafur is the main raw material used in the production of FMCG products. It is a key ingredient in detergents, paints & coatings, and plastics industries. The demand for Tegafur has been growing at a steady pace owing to its usage as an additive in plastic manufacturing and increasing consumption of paints & coatings globally.
Purity ≥ 99 %:
Tegafur is a chemical intermediate used in the production of fertilizers and specialty polymers. It is manufactured by the catalytic oxidation of uronate (UO2+). The product has applications in agriculture, pharmaceuticals, chemicals, and oil & gas industries. Uronium oxide which is a by-product of tegafur manufacturing process can be utilized as an additive to improve crop yield quality and nutritional value along with providing protection against UV radiation damage.
Application Insights:
Tegafur injection was the dominant application segment in the global Tegafur API market and accounted for over 60.0% of the revenue share in 2017. The product is used as a raw material for manufacturing various industrial solvents, adhesives, coatings and emulsifiers among others. It is also employed as an agricultural fumigant owing to its high toxicity towards insects and rodents when mixed with other compounds such as paraffin wax or petroleum distillates among others.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its dominance over the forecast period owing to increasing R&D activities and presence of key manufacturers. In addition, rising prevalence of kidney cancer is also one of the major factors driving regional growth. For instance, as per statistics published by National Cancer Institute (NCI), around 1,849 new cases were reported in U.S.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to growing awareness about advanced treatment options among patients suffering from kidney cancer.
Growth Factors:
- Increasing demand for anticancer drugs
- Growing prevalence of cancer
- Rising awareness about the benefits of Tegafur API therapy
- Technological advancements in drug discovery and development process
- Availability of government funding for research and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Tegafur API Market Research Report
By Type
Purity ≥ 98 %, Purity ≥ 99 %
By Application
Tegafur Injection, Other
By Companies
Cipla, Gindeks, Qilu Pharmaceutial, KPS Chemicals and Pharmaceutical, ICE Pharma Group, Asia Talent Chemical, Cipla
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Tegafur API Market Report Segments:
The global Tegafur API market is segmented on the basis of:
Types
Purity ≥ 98 %, Purity ≥ 99 %
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tegafur Injection, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cipla
- Gindeks
- Qilu Pharmaceutial
- KPS Chemicals and Pharmaceutical
- ICE Pharma Group
- Asia Talent Chemical
- Cipla
Highlights of The Tegafur API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity ≥ 98 %
- Purity ≥ 99 %
- By Application:
- Tegafur Injection
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tegafur API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Tegafur API is a platform-agnostic interface that enables developers to access and manage their Tegafur data. The API provides access to all of the functionality available in the Tegafur platform, including data management, reporting, analytics, and more.
Some of the major players in the tegafur api market are Cipla, Gindeks, Qilu Pharmaceutial, KPS Chemicals and Pharmaceutical, ICE Pharma Group, Asia Talent Chemical, Cipla.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tegafur API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tegafur API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tegafur API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tegafur API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tegafur API Market Size & Forecast, 2018-2028
4.5.1 Tegafur API Market Size and Y-o-Y Growth
4.5.2 Tegafur API Market Absolute $ Opportunity
Chapter 5 Global Tegafur API Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tegafur API Market Size Forecast by Type
5.2.1 Purity ≥ 98 %
5.2.2 Purity ≥ 99 %
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tegafur API Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tegafur API Market Size Forecast by Applications
6.2.1 Tegafur Injection
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tegafur API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tegafur API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tegafur API Analysis and Forecast
9.1 Introduction
9.2 North America Tegafur API Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tegafur API Market Size Forecast by Type
9.6.1 Purity ≥ 98 %
9.6.2 Purity ≥ 99 %
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tegafur API Market Size Forecast by Applications
9.10.1 Tegafur Injection
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tegafur API Analysis and Forecast
10.1 Introduction
10.2 Europe Tegafur API Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tegafur API Market Size Forecast by Type
10.6.1 Purity ≥ 98 %
10.6.2 Purity ≥ 99 %
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tegafur API Market Size Forecast by Applications
10.10.1 Tegafur Injection
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tegafur API Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tegafur API Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tegafur API Market Size Forecast by Type
11.6.1 Purity ≥ 98 %
11.6.2 Purity ≥ 99 %
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tegafur API Market Size Forecast by Applications
11.10.1 Tegafur Injection
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tegafur API Analysis and Forecast
12.1 Introduction
12.2 Latin America Tegafur API Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tegafur API Market Size Forecast by Type
12.6.1 Purity ≥ 98 %
12.6.2 Purity ≥ 99 %
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tegafur API Market Size Forecast by Applications
12.10.1 Tegafur Injection
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tegafur API Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tegafur API Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tegafur API Market Size Forecast by Type
13.6.1 Purity ≥ 98 %
13.6.2 Purity ≥ 99 %
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tegafur API Market Size Forecast by Applications
13.10.1 Tegafur Injection
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tegafur API Market: Competitive Dashboard
14.2 Global Tegafur API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cipla
14.3.2 Gindeks
14.3.3 Qilu Pharmaceutial
14.3.4 KPS Chemicals and Pharmaceutical
14.3.5 ICE Pharma Group
14.3.6 Asia Talent Chemical
14.3.7 Cipla
